Filing Details
- Accession Number:
- 0001209191-21-054825
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-03 17:22:06
- Reporting Period:
- 2021-09-02
- Accepted Time:
- 2021-09-03 17:22:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1107421 | Ziopharm Oncology Inc | ZIOP | Pharmaceutical Preparations (2834) | 841475642 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1827847 | W Robert Postma | C/O Ziopharm Oncology, Inc. One First Avenue, Parris Bldg 34 Boston MA 02129 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-09-02 | 20,508 | $1.73 | 1,201,870 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2021-09-02 | 54,492 | $1.73 | 4,250,000 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Indirect | See footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 3,574 | Indirect | By Spouse's IRA |
Footnotes
- Includes 946,970 shares of common stock underlying the Units. The Reporting Person purchased 946,970 units of the Issuer (the "Units") for $2.64 per Unit in a private placement transaction with the Issuer. Each Unit consists of one share of common stock and a warrant to acquire one share of common stock.
- The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.
Billionaire Hedge Funds
